AbCellera Biologics (ABCL) News Today $4.24 +0.23 (+5.74%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$4.32 +0.08 (+1.77%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABCL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period AbCellera Biologics (NASDAQ:ABCL) Sets New 52-Week High After Analyst Upgrade3 hours ago | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Stock Price Up 8.9% on Analyst UpgradeJuly 14 at 11:31 AM | marketbeat.comKeyCorp Boosts AbCellera Biologics (NASDAQ:ABCL) Price Target to $10.00July 14 at 9:04 AM | marketbeat.comMoloney Securities Asset Management LLC Reduces Stake in AbCellera Biologics Inc. (NASDAQ:ABCL)July 12 at 5:08 AM | marketbeat.comBrokerages Set AbCellera Biologics Inc. (NASDAQ:ABCL) Target Price at $7.50July 11, 2025 | americanbankingnews.comQ2 Earnings Forecast for ABCL Issued By Leerink PartnrsJuly 10, 2025 | americanbankingnews.comAbCellera Biologics (NASDAQ:ABCL) Reaches New 52-Week High - Should You Buy?July 9, 2025 | marketbeat.comResearch Analysts Set Expectations for ABCL Q2 EarningsJuly 9, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Now Covered by Analysts at Leerink PartnersJuly 9, 2025 | americanbankingnews.comTruist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy RatingJuly 8, 2025 | msn.comAbCellera Biologics Inc. (NASDAQ:ABCL) Receives Average Recommendation of "Moderate Buy" from BrokeragesJuly 8, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Upgraded at Leerink PartnrsJuly 8, 2025 | marketbeat.comAbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025July 7, 2025 | businesswire.comAbCellera Biologics (NASDAQ:ABCL) Trading Up 6.2% - Should You Buy?July 7, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Coverage Initiated by Analysts at Leerink PartnersJuly 7, 2025 | marketbeat.comWe're Interested To See How AbCellera Biologics (NASDAQ:ABCL) Uses Its Cash Hoard To GrowJune 30, 2025 | finance.yahoo.comAbCellera Biologics (NASDAQ:ABCL) Sets New 52-Week High - Should You Buy?June 25, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Shares Up 8% - Time to Buy?June 24, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Shares Down 4.9% - Time to Sell?June 20, 2025 | marketbeat.comAbCellera Biologics: The Dilemma Of A Promising Pipeline Alongside Cash BurnJune 13, 2025 | seekingalpha.comAbCellera Biologics (NASDAQ:ABCL) Shares Gap Down - Should You Sell?June 13, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Shares Gap Up - Time to Buy?June 11, 2025 | marketbeat.comAbCellera Biologics Target of Unusually High Options Trading (NASDAQ:ABCL)June 11, 2025 | marketbeat.comAbCellera Biologics Inc. (ABCL): A Bull Case TheoryJune 10, 2025 | finance.yahoo.comAbCellera Biologics (NASDAQ:ABCL) Stock Price Up 10.6% - Should You Buy?June 10, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Stock Price Up 8.9% - Here's What HappenedJune 4, 2025 | marketbeat.comWhy AbCellera Biologics Stock Raced Nearly 6% Higher TodayJune 2, 2025 | fool.comAbCellera Biologics Inc. (ABCL) Approved to Begin ABCL575 Trial for Atopic DermatitisMay 31, 2025 | insidermonkey.comAbCellera Biologics Inc. (NASDAQ:ABCL) Stock Holdings Boosted by Millennium Management LLCMay 31, 2025 | marketbeat.comAbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575May 30, 2025 | businesswire.comTwo Sigma Investments LP Increases Stock Position in AbCellera Biologics Inc. (NASDAQ:ABCL)May 27, 2025 | marketbeat.comTwo Sigma Advisers LP Buys 430,800 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL)May 26, 2025 | marketbeat.comAbCellera Biologics Inc. (ABCL): Analysts See 474% Upside PotentialMay 21, 2025 | insidermonkey.comTang Capital Management LLC Grows Position in AbCellera Biologics Inc. (NASDAQ:ABCL)May 20, 2025 | marketbeat.comAbCellera Biologics Inc. (NASDAQ:ABCL) Shares Sold by Lazard Asset Management LLCMay 19, 2025 | marketbeat.comTruist Financial Remains a Buy on AbCellera Biologics (ABCL)May 18, 2025 | theglobeandmail.comAbCellera Biologics Inc. (NASDAQ:ABCL) is Prosight Management LP's 5th Largest PositionMay 17, 2025 | marketbeat.comAnalyst Forecasts Just Became More Bearish On AbCellera Biologics Inc. (NASDAQ:ABCL)May 16, 2025 | uk.finance.yahoo.comAbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to MenopauseMay 14, 2025 | businesswire.comAbCellera’s Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal CircuitMay 12, 2025 | finance.yahoo.comAbCellera Biologics (NASDAQ:ABCL) Announces Earnings ResultsMay 11, 2025 | marketbeat.comAbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual MeetingMay 9, 2025 | businesswire.comAbCellera plans to advance ABCL635 and ABCL575 into Phase 1 trials in Q3 2025May 9, 2025 | msn.comAbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comAbCellera Biologics Inc. 2025 Q1 - Results - Earnings Call PresentationMay 8, 2025 | seekingalpha.comAbCellera Biologics Q1 2025 Earnings PreviewMay 8, 2025 | msn.comAbCellera Biologics (NASDAQ:ABCL) Trading Down 6.8% - What's Next?May 7, 2025 | marketbeat.comAbCellera Biologics (ABCL) Projected to Post Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comWalleye Capital LLC Reduces Holdings in AbCellera Biologics Inc. (NASDAQ:ABCL)April 30, 2025 | marketbeat.comAbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025April 29, 2025 | businesswire.com Get AbCellera Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABCL and its competitors with MarketBeat's FREE daily newsletter. Email Address ABCL Media Mentions By Week ABCL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABCL News Sentiment▼0.780.99▲Average Medical News Sentiment ABCL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABCL Articles This Week▼174▲ABCL Articles Average Week Get AbCellera Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABCL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRISPR Therapeutics News Today ADMA Biologics News Today Rhythm Pharmaceuticals News Today Vaxcyte News Today Akero Therapeutics News Today Krystal Biotech News Today Cytokinetics News Today Zai Lab News Today PTC Therapeutics News Today Ultragenyx Pharmaceutical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABCL) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
